Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike
September 4, 2016
Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.
Mark Baum / Imprimis Pharmceuticals
Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.
"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.
"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."
Click Here For The Most Popular On Sunny Skyz
Couple Rescues Prairie Dog From Their Dog's Mouth, Then Decides To Adopt It
My Girlfriend Gifted Me My Father’s Handwriting To Keep Forever
We Can’t Stop Looking At These Adorable Baby Loon Photos Taken On A Lake
This Couple Built A Grass Patch For Their Cat, And She’s Obsessed With It
This All-Black ‘Goth House’ In Indiana Is Going Viral. Wait Until You See The Inside
Meet Igor: The Fluffy Poltergeist Dog With The Most Unhinged Adoption Bio Ever
Baby Elephant’s Trunk Steals The Show In Adorable Treat Time Video
What Happens When A Man With A Hose Meets A Group of Kids? Pure Magic
Chicken Or Pigeon? The Internet Can’t Believe This Bird Is Real
Mom Surprises 4-Year-Old Son With First Apartment After 14 Months In Homeless Shelter
Bear Vs. Sprinkler: Hilarious Garden Moment Caught On Camera
